How healthy participants value additional diagnostic testing with amyloid-PET in patients diagnosed with mild cognitive impairment — a bidding game experiment

BACKGROUND: To estimate the perceived value of additional testing with amyloid-PET in Euros in healthy participants acting as analogue patients with mild cognitive impairment (MCI). METHODS: One thousand four hundred thirty-one healthy participants acting as analogue MCI patients (mean age 65 ± 8, 9...

Descripción completa

Detalles Bibliográficos
Autores principales: van Maurik, I. S., Bakker, E. D., van Unnik, A. A. J. M., Broulikova, H. M., Zwan, M. D., van de Giessen, E., Berkhof, J., Bouwman, F. H., Bosmans, J. E., van der Flier, W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683285/
https://www.ncbi.nlm.nih.gov/pubmed/38017549
http://dx.doi.org/10.1186/s13195-023-01346-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683285/
https://www.ncbi.nlm.nih.gov/pubmed/38017549
http://dx.doi.org/10.1186/s13195-023-01346-y

Ejemplares similares